Skip to main content
Premium Trial:

Request an Annual Quote

BAG Diagnostics Gets CE Mark for Coronavirus MDx Test

NEW YORK – Germany's BAG Diagnostics said on Thursday that its ViroQ SARS-CoV-2 rapid PCR test has received CE IVD marking.

BAG Diagnostics' test is designed to detect SARS-CoV-2 genes E and RdRP in respiratory samples, according to the company's website. The company said that the assay's ability to detect a housekeeping gene that occurs in all cells can determine whether sufficient cell material is available for valid results, helping to eliminate false negatives.

Each kit is designed to perform 100 tests, and the kits can be shipped at ambient temperature but necessitate storage at -20° C. BAG Diagnostics said the test should be able to be performed with all RNA isolation kits and has been tested with kits from Qiagen and Sigma-Aldrich.

In addition, the three fluorescent dyes used in the assay are compatible with common real-time PCR cyclers and have been tested on Thermo Fisher Scientific's QuantStudio 6, Bio-Rad's CFX 96TM, and Roche's Lightcycler 480.

The company said that the test will be made available in all territories recognizing CE marking.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more